Double-stranded RNA binding by the human cytomegalovirus PKR antagonist TRS1

Virology

Volumn 442, Issue 1, 2013, Pages 28-37

  Bierle, Craig J ^a,b   Semmens, Kathryn M ^a,b   Geballe, Adam P ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

Author keywords

Cytomegalovirus; Double stranded RNA; EIF2 ; Protein kinase R; TRS1; US22 gene family

Indexed keywords

ARGININE; BINDING PROTEIN; DOUBLE STRANDED RNA; PROTEIN KINASE R; PROTEIN SERINE THREONINE KINASE INHIBITOR; TRS1 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; BINDING SITE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; ENZYME ACTIVATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; INHIBITION KINETICS; INSECT CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; POINT MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PURIFICATION; PROTEIN RNA BINDING; SEQUENCE ALIGNMENT; SITE DIRECTED MUTAGENESIS; VACCINIA VIRUS; VIRUS REPLICATION;

ANIMALS; CELLS, CULTURED; COS CELLS; CYTOMEGALOVIRUS; EIF-2 KINASE; FIBROBLASTS; HELA CELLS; HUMANS; POINT MUTATION; RNA, DOUBLE-STRANDED; SPODOPTERA; VIRAL PROTEINS; VIRUS REPLICATION;

CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 5; VACCINIA VIRUS;

EID: 84878900854     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2013.03.024     Document Type: Article

References (60)

1. Adamo J.E., Schroer J., Shenk T. Human cytomegalovirus TRS1 protein is required for efficient assembly of DNA-containing capsids. J. Virol. 2004, 78(19):10221-10229.
2. Alexopoulou L., Holt A.C., Medzhitov R., Flavell R.A. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 2001, 413(6857):732-738.
3. Beattie E., Denzler K.L., Tartaglia J., Perkus M.E., Paoletti E., Jacobs B.L. Reversal of the interferon-sensitive phenotype of a vaccinia virus lacking E3L by expression of the reovirus S4 gene. J. Virol. 1995, 69(1):499-505.
4. Beattie E., Kauffman E.B., Martinez H., Perkus M.E., Jacobs B.L., Paoletti E., Tartaglia J. Host-range restriction of vaccinia virus E3L-specific deletion mutants. Virus Genes 1996, 12(1):89-94.
5. Bevilacqua P.C., Cech T.R. Minor-groove recognition of double-stranded RNA by the double-stranded RNA-binding domain from the RNA-activated protein kinase PKR. Biochemistry 1996, 35(31):9983-9994.
6. Bierle C.J., Schleiss M.R., Geballe A.P. Antagonism of the protein kinase R pathway by the guinea pig cytomegalovirus US22-family gene gp145. Virology 2012, 433(1):157-166.
7. Blankenship C.A., Shenk T. Mutant human cytomegalovirus lacking the immediate-early TRS1 coding region exhibits a late defect. J. Virol. 2002, 76(23):12290-12299.
8. Budt M., Niederstadt L., Valchanova R.S., Jonjic S., Brune W. Specific inhibition of the PKR-mediated antiviral response by the murine cytomegalovirus proteins m142 and m143. J. Virol. 2009, 83(3):1260-1270.
9. Carven G.J., Stern L.J. Probing the ligand-induced conformational change in HLA-DR1 by selective chemical modification and mass spectrometric mapping. Biochemistry 2005, 44(42):13625-13637.
10. Chaumorcel M., Lussignol M., Mouna L., Cavignac Y., Fahie K., Cotte-Laffitte J., Geballe A., Brune W., Beau I., Codogno P., Esclatine A. The human cytomegalovirus protein TRS1 inhibits autophagy via its interaction with Beclin 1. J. Virol. 2012, 86(5):2571-2584.
11. Chien C.Y., Xu Y., Xiao R., Aramini J.M., Sahasrabudhe P.V., Krug R.M., Montelione G.T. Biophysical characterization of the complex between double-stranded RNA and the N-terminal domain of the NS1 protein from influenza A virus: evidence for a novel RNA-binding mode. Biochemistry 2004, 43(7):1950-1962.
12. Child S.J., Brennan G., Braggin J.E., Geballe A.P. Species specificity of protein kinase R antagonism by cytomegalovirus TRS1 genes. J. Virol. 2012, 86(7):3880-3889.
13. Child S.J., Geballe A.P. Binding and relocalization of protein kinase R by murine cytomegalovirus. J. Virol. 2009, 83(4):1790-1799.
14. Child S.J., Hakki M., De Niro K.L., Geballe A.P. Evasion of cellular antiviral responses by human cytomegalovirus TRS1 and IRS1. J. Virol. 2004, 78(1):197-205.
15. Child S.J., Hanson L.K., Brown C.E., Janzen D.M., Geballe A.P. Double-stranded RNA binding by a heterodimeric complex of murine cytomegalovirus m142 and m143 proteins. J. Virol. 2006, 80(20):10173-10180.
16. Child S.J., Jarrahian S., Harper V.M., Geballe A.P. Complementation of vaccinia virus lacking the double-stranded RNA-binding protein gene E3L by human cytomegalovirus. J. Virol. 2002, 76(10):4912-4918.
17. Chothia C. The nature of the accessible and buried surfaces in proteins. J. Mol. Biol. 1976, 105(1):1-12.
18. Conn G.L. Expression of active RNA-activated protein kinase (PKR) in bacteria. Biotechniques 2003, 35(4):682-684. 686.
19. Dever T.E., Dar A.C., Scheri F. The eIF2α Kinases. Translational Control in Biology and Medicine 2007, 319-344. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY. 3rd ed. M. Mathews, N. Sonenberg, J.W.B. Hershey (Eds.).
20. Elde N.C., Child S.J., Eickbush M.T., Kitzman J.O., Rogers K.S., Shendure J., Geballe A.P., Malik H.S. Poxviruses deploy genomic accordions to adapt rapidly against host antiviral defenses. Cell 2012, 150(4):831-841.
21. Garcia M.A., Gil J., Ventoso I., Guerra S., Domingo E., Rivas C., Esteban M. Impact of protein kinase PKR in cell biology: from antiviral to antiproliferative action. Microbiol. Mol. Biol. Rev. 2006, 70(4):1032-1060.
22. Geballe A.P., Mocarski E.S. Translational control of cytomegalovirus gene expression is mediated by upstream AUG codons. J. Virol. 1988, 62(9):3334-3340.
23. Guerra S., Caceres A., Knobeloch K.P., Horak I., Esteban M. Vaccinia virus E3 protein prevents the antiviral action of ISG15. PLoS Pathog. 2008, 4(7):e1000096.
24. Hakki M., Geballe A.P. Double-stranded RNA binding by human cytomegalovirus pTRS1. J. Virol. 2005, 79(12):7311-7318.
25. Hakki M., Marshall E.E., De Niro K.L., Geballe A.P. Binding and nuclear relocalization of protein kinase R by human cytomegalovirus TRS1. J. Virol. 2006, 80(23):11817-11826.
26. Hewitt L., McDonnell J.M. Screening and optimizing protein production in E. coli. Methods Mol. Biol. 2004, 278:1-16.
27. Ho C.K., Shuman S. Physical and functional characterization of the double-stranded RNA binding protein encoded by the vaccinia virus E3 gene. Virology 1996, 217(1):272-284.
28. Kagele D., Rossetto C.C., Tarrant M.T., Pari G.S. Analysis of the interactions of viral and cellular factors with human cytomegalovirus lytic origin of replication, oriLyt. Virology 2012, 424(2):106-114.
29. Kato H., Takeuchi O., Sato S., Yoneyama M., Yamamoto M., Matsui K., Uematsu S., Jung A., Kawai T., Ishii K.J., Yamaguchi O., Otsu K., Tsujimura T., Koh C.S., Reis e Sousa C., Matsuura Y., Fujita T., Akira S. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 2006, 441(7089):101-105.
30. Kharrat A., Macias M.J., Gibson T.J., Nilges M., Pastore A. Structure of the dsRNA binding domain of E. coli RNase III. EMBO J. 1995, 14(14):3572-3584.
31. Khoo D., Perez C., Mohr I. Characterization of RNA determinants recognized by the arginine- and proline-rich region of Us11, a herpes simplex virus type 1-encoded double-stranded RNA binding protein that prevents PKR activation. J. Virol. 2002, 76(23):11971-11981.
32. Langland J.O., Cameron J.M., Heck M.C., Jancovich J.K., Jacobs B.L. Inhibition of PKR by RNA and DNA viruses. Virus Res. 2006, 119(1):100-110.
33. Langland J.O., Jacobs B.L. Inhibition of PKR by vaccinia virus: role of the N- and C-terminal domains of E3L. Virology 2004, 324(2):419-429.
34. Langland J.O., Pettiford S.M., Jacobs B.L. Nucleic acid affinity chromatography: preparation and characterization of double-stranded RNA agarose. Protein Expr. Purif. 1995, 6(1):25-32.
35. Lee S.B., Esteban M. The interferon-induced double-stranded RNA-activated protein kinase induces apoptosis. Virology 1994, 199(2):491-496.
36. Lemaire P.A., Anderson E., Lary J., Cole J.L. Mechanism of PKR Activation by dsRNA. J. Mol. Biol. 2008, 381(2):351-360.
37. Li S., Min J.Y., Krug R.M., Sen G.C. Binding of the influenza A virus NS1 protein to PKR mediates the inhibition of its activation by either PACT or double-stranded RNA. Virology 2006, 349(1):13-21.
38. Liu Y., Wolff K.C., Jacobs B.L., Samuel C.E. Vaccinia virus E3L interferon resistance protein inhibits the interferon-induced adenosine deaminase A-to-I editing activity. Virology 2001, 289(2):378-387.
39. Manche L., Green S.R., Schmedt C., Mathews M.B. Interactions between double-stranded RNA regulators and the protein kinase DAI. Mol. Cell. Biol. 1992, 12(11):5238-5248.
40. Marshall E.E., Bierle C.J., Brune W., Geballe A.P. Essential role for either TRS1 or IRS1 in human cytomegalovirus replication. J. Virol. 2009, 83(9):4112-4120.
41. McCormack S.J., Samuel C.E. Mechanism of interferon action: RNA-binding activity of full-length and R-domain forms of the RNA-dependent protein kinase PKR - determination of KD values for VAI and TAR RNAs. Virology 1995, 206(1):511-519.
42. McKee C.J., Kessl J.J., Norris J.O., Shkriabai N., Kvaratskhelia M. Mass spectrometry-based footprinting of protein-protein interactions. Methods 2009, 47(4):304-307.
43. Mendoza V.L., Vachet R.W. Probing protein structure by amino acid-specific covalent labeling and mass spectrometry. Mass Spectrom. Rev. 2009, 28(5):785-815.
44. Ramos A., Grunert S., Adams J., Micklem D.R., Proctor M.R., Freund S., Bycroft M., Johnston D., Varani G. RNA recognition by a Staufen double-stranded RNA-binding domain. EMBO J. 2000, 19(5):997-1009.
45. Rivas C., Gil J., Melkova Z., Esteban M., Diaz-Guerra M. Vaccinia virus E3L protein is an inhibitor of the interferon (i.f.n.)-induced 2-5A synthetase enzyme. Virology 1998, 243(2):406-414.
46. Romano P.R., Zhang F., Tan S.L., Garcia-Barrio M.T., Katze M.G., Dever T.E., Hinnebusch A.G. Inhibition of double-stranded RNA-dependent protein kinase PKR by vaccinia virus E3: role of complex formation and the E3 N-terminal domain. Mol. Cell. Biol. 1998, 18(12):7304-7316.
47. Ryder S.P., Recht M.I., Williamson J.R. Quantitative analysis of protein-RNA interactions by gel mobility shift. Methods Mol. Biol. 2008, 488:99-115.
48. Schmedt C., Green S.R., Manche L., Taylor D.R., Ma Y., Mathews M.B. Functional characterization of the RNA-binding domain and motif of the double-stranded RNA-dependent protein kinase DAI (PKR). J. Mol. Biol. 1995, 249(1):29-44.
49. Shors T., Kibler K.V., Perkins K.B., Seidler-Wulff R., Banaszak M.P., Jacobs B.L. Complementation of vaccinia virus deleted of the E3L gene by mutants of E3L. Virology 1997, 239(2):269-276.
50. Smith E.J., Marie I., Prakash A., Garcia-Sastre A., Levy D.E. IRF3 and IRF7 phosphorylation in virus-infected cells does not require double-stranded RNA-dependent protein kinase R or Ikappa B kinase but is blocked by Vaccinia virus E3L protein. J. Biol. Chem. 2001, 276(12):8951-8957.
51. Stasiak P.C., Mocarski E.S. Transactivation of the cytomegalovirus ICP36 gene promoter requires the alpha gene product TRS1 in addition to IE1 and IE2. J. Virol. 1992, 66(2):1050-1058.
52. Strang B.L., Geballe A.P., Coen D.M. Association of human cytomegalovirus proteins IRS1 and TRS1 with the viral DNA polymerase accessory subunit UL44. J. Gen. Virol. 2010, 91(Pt 9):2167-2175.
53. Tan S.L., Katze M.G. Biochemical and genetic evidence for complex formation between the influenza A virus NS1 protein and the interferon-induced PKR protein kinase. J. Interferon. Cytokine Res. 1998, 18(9):757-766.
54. Valchanova R.S., Picard-Maureau M., Budt M., Brune W. Murine cytomegalovirus m142 and m143 are both required to block protein kinase R-mediated shutdown of protein synthesis. J. Virol. 2006, 80(20):10181-10190.
55. Wang W., Riedel K., Lynch P., Chien C.Y., Montelione G.T., Krug R.M. RNA binding by the novel helical domain of the influenza virus NS1 protein requires its dimer structure and a small number of specific basic amino acids. RNA 1999, 5(2):195-205.
56. Wang Z., Choi M.K., Ban T., Yanai H., Negishi H., Lu Y., Tamura T., Takaoka A., Nishikura K., Taniguchi T. Regulation of innate immune responses by DAI (DLM-1/ZBP1) and other DNA-sensing molecules. Proc. Natl. Acad. Sci. U. S. A. 2008, 105(14):5477-5482.
57. Weber F., Wagner V., Rasmussen S.B., Hartmann R., Paludan S.R. Double-stranded RNA is produced by positive-strand RNA viruses and DNA viruses but not in detectable amounts by negative-strand RNA viruses. J. Virol. 2006, 80(10):5059-5064.
58. White S.D., Jacobs B.L. The amino terminus of vaccinia virus E3 protein is necessary to inhibit the interferon response. J. Virol. 2012, 5895-5904.
59. Yoneyama M., Kikuchi M., Natsukawa T., Shinobu N., Imaizumi T., Miyagishi M., Taira K., Akira S., Fujita T. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 2004, 5(7):730-737.
60. Zhang P., Jacobs B.L., Samuel C.E. Loss of protein kinase PKR expression in human HeLa cells complements the vaccinia virus E3L deletion mutant phenotype by restoration of viral protein synthesis. J. Virol. 2008, 82(2):840-848.